1. Home
  2. TECH vs TIMB Comparison

TECH vs TIMB Comparison

Compare TECH & TIMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • TIMB
  • Stock Information
  • Founded
  • TECH 1976
  • TIMB 1998
  • Country
  • TECH United States
  • TIMB Brazil
  • Employees
  • TECH N/A
  • TIMB N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • TIMB Telecommunications Equipment
  • Sector
  • TECH Health Care
  • TIMB Telecommunications
  • Exchange
  • TECH Nasdaq
  • TIMB Nasdaq
  • Market Cap
  • TECH 7.9B
  • TIMB 8.0B
  • IPO Year
  • TECH 1989
  • TIMB 1998
  • Fundamental
  • Price
  • TECH $49.94
  • TIMB $17.18
  • Analyst Decision
  • TECH Buy
  • TIMB Hold
  • Analyst Count
  • TECH 10
  • TIMB 4
  • Target Price
  • TECH $73.44
  • TIMB $17.00
  • AVG Volume (30 Days)
  • TECH 2.2M
  • TIMB 337.6K
  • Earning Date
  • TECH 05-07-2025
  • TIMB 05-20-2025
  • Dividend Yield
  • TECH 0.64%
  • TIMB 6.92%
  • EPS Growth
  • TECH N/A
  • TIMB 17.22
  • EPS
  • TECH 0.83
  • TIMB 0.25
  • Revenue
  • TECH $1,208,770,000.00
  • TIMB $4,490,458,172.00
  • Revenue This Year
  • TECH $8.19
  • TIMB $8.10
  • Revenue Next Year
  • TECH $8.61
  • TIMB $4.87
  • P/E Ratio
  • TECH $60.17
  • TIMB $13.99
  • Revenue Growth
  • TECH 4.72
  • TIMB 6.00
  • 52 Week Low
  • TECH $46.44
  • TIMB $11.32
  • 52 Week High
  • TECH $85.57
  • TIMB $18.39
  • Technical
  • Relative Strength Index (RSI)
  • TECH 44.19
  • TIMB 65.35
  • Support Level
  • TECH $46.77
  • TIMB $17.13
  • Resistance Level
  • TECH $50.81
  • TIMB $17.68
  • Average True Range (ATR)
  • TECH 2.02
  • TIMB 0.34
  • MACD
  • TECH 0.41
  • TIMB 0.09
  • Stochastic Oscillator
  • TECH 46.82
  • TIMB 76.85

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About TIMB TIM S.A. (Each representing 5)

TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.

Share on Social Networks: